tiprankstipranks
Advertisement
Advertisement
Adicet Bio: Cash Runway to 2027 and Differentiated Allogeneic Prula‑cel Pipeline Support Buy Rating and $27 Target
PremiumRatingsAdicet Bio: Cash Runway to 2027 and Differentiated Allogeneic Prula‑cel Pipeline Support Buy Rating and $27 Target
3M ago
Adicet Bio price target lowered to $27 from $50 at H.C. Wainwright
Premium
The Fly
Adicet Bio price target lowered to $27 from $50 at H.C. Wainwright
3M ago
Clinical Trial Uncertainty Puts Adicet Bio’s Prula-cel Program and Financial Outlook at Risk
Premium
Company Announcements
Clinical Trial Uncertainty Puts Adicet Bio’s Prula-cel Program and Financial Outlook at Risk
4M ago
Adicet Bio price target adjusted to $50 from $9 at H.C. Wainwright
PremiumThe FlyAdicet Bio price target adjusted to $50 from $9 at H.C. Wainwright
5M ago
Adicet Bio advances prula-cel autoimmune Phase 1 program
Premium
Company Announcements
Adicet Bio advances prula-cel autoimmune Phase 1 program
6M ago
Adicet Bio price target lowered to $18 from $128 at Canaccord
Premium
The Fly
Adicet Bio price target lowered to $18 from $128 at Canaccord
6M ago
Vanguard Total Stock Market ETF (VTI) Daily Update—12/29/25
PremiumMarket NewsVanguard Total Stock Market ETF (VTI) Daily Update—12/29/25
6M ago
Upcoming Stock Splits This Week (December 29 to January 2) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (December 29 to January 2) – Stay Invested
6M ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/24/25
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/24/25
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100